Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.83) by 4.82 percent. This is a 11.24 percent increase over losses of $(0.89) per share from the same period last year.
Why Virgin Galactic (SPCE) Shares Are Moving
Virgin Galactic shares are trading higher by 12.8% during Monday's session. The company announced the opening of a new system integration facility in Southern California.
